no, 최신 재무제표에 따르면 Regeneron Pharmaceuticals Inc의 순손실은 $0입니다.
Masterworks 082 LLC에 부채가 있나요?
no, Regeneron Pharmaceuticals Inc의 부채는 0입니다.
Masterworks 082 LLC의 발행 주식은 몇 주인가요?
Regeneron Pharmaceuticals Inc의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$8.4
시가
$7.9
일일 범위
$7.9 - $7.9
52주 범위
$5.89 - $8
거래량
--
평균 거래량
318
배당수익률
--
EPS(TTM)
--
시가총액
--
MSWOS란 무엇인가요?
Masterworks 082 LLC engages in providing retails artwork products and provides management services. The company is headquartered in New York City, New York. The company went IPO on 2025-02-27. The firm does not conduct any business activities except for activities relating to the ownership, maintenance, promotion and the eventual sale of the Artwork. The company is managed by its affiliate, Masterworks Administrative Services, LLC (the Administrator).